TrialJournal of comparative effectiveness research2024

Polymer-based drug-eluting stent treatment extends the time to reintervention for patients with symptomatic femoropopliteal artery disease: clinical evidence and potential economic value.

William A Gray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.